Ismigen, also known by its trade name, OM-85 BV, is an immunostimulant developed to enhance the body's immune defense mechanisms. The drug is primarily indicated for the prevention of
recurrent respiratory tract infections, particularly in individuals with weakened immune systems, such as children, the elderly, and those with
chronic respiratory conditions. Ismigen is a bacterial lysate, meaning it is composed of fragments from multiple strains of bacteria, including Haemophilus influenzae, Streptococcus pneumoniae, Klebsiella pneumoniae, and Moraxella catarrhalis. These bacterial components are inactivated and formulated into a drug that can elicit an immune response without causing disease.
Developed by the Swiss pharmaceutical company
OM Pharma S.A., Ismigen has undergone extensive research and clinical trials to establish its efficacy and safety profile. Research institutions worldwide have conducted studies to scrutinize the drug's effectiveness in reducing the frequency and severity of
respiratory infections. The results have consistently shown that Ismigen can significantly lower the incidence of such
infections, thereby reducing the need for antibiotics and other medications.
The drug is available in various forms, including oral tablets, which makes it easy to administer, especially in pediatric and geriatric populations. Its ability to modulate the immune system has also garnered interest in exploring its potential applications in other areas, such as
allergy prevention and
autoimmune diseases.
Ismigen Mechanism of Action
Ismigen works by modulating the immune system, enhancing both its innate and adaptive responses. The drug contains fragments from multiple bacterial species, which act as antigens when introduced into the body. These bacterial fragments are recognized by the immune system as foreign invaders, triggering a response that mimics a natural infection. This process, known as immunostimulation, primes the immune system to respond more effectively to actual infections.
The bacterial lysates in Ismigen activate various components of the immune system, including macrophages, dendritic cells, and lymphocytes. These cells play crucial roles in identifying and eliminating pathogens. The activation of macrophages and dendritic cells leads to the production of cytokines, which are signaling proteins that orchestrate the immune response. These cytokines enhance the activity of T-cells and B-cells, which are essential for adaptive immunity. T-cells help in recognizing and destroying infected cells, while B-ccells produce antibodies that neutralize pathogens.
Moreover, Ismigen has been found to increase the levels of secretory IgA (sIgA) in the respiratory mucosa. sIgA is an antibody that plays a critical role in mucosal immunity, serving as the first line of defense against pathogens entering through the respiratory tract. By boosting the levels of sIgA, Ismigen enhances the body's ability to prevent infections at their entry point.
How to Use Ismigen
Ismigen is typically administered orally, and the dosage regimen can vary based on the patient's age, health condition, and specific medical needs. For adults and children over the age of 12, the standard dosage is one tablet daily for ten consecutive days each month, over a period of three months. For younger children, the dosage might be adjusted, and it is crucial to follow the prescribing physician's recommendations.
The tablets should be taken on an empty stomach to ensure optimal absorption. It is recommended to swallow the tablets whole with a glass of water. In cases where patients, particularly young children, have difficulty swallowing tablets, the tablet can be dissolved in a small amount of water to make ingestion easier.
The onset of action for Ismigen may vary based on individual immune responses, but improvements in immune function and a reduction in infection frequency are usually observed within the first few months of therapy. It is essential to complete the entire course as prescribed to achieve the maximum therapeutic benefit.
What is Ismigen Side Effects
While Ismigen is generally well-tolerated, it is not without potential side effects. Common side effects include gastrointestinal symptoms such as
nausea,
vomiting,
diarrhea, and
abdominal pain. These symptoms are usually mild and transient, resolving without the need for medical intervention.
In some cases, patients may experience allergic reactions, which can manifest as
skin rashes,
itching, and, rarely, more severe reactions like
angioedema or
anaphylaxis. If any signs of an allergic reaction occur, it is essential to seek immediate medical attention.
Contraindications for Ismigen include hypersensitivity to any of the drug's components. Individuals with autoimmune disorders should use Ismigen with caution, as stimulating the immune system might exacerbate their condition. It is also advised to avoid using Ismigen during acute infections, as the drug is intended for prophylactic use rather than for treating active infections.
What Other Drugs Will Affect Ismigen
Ismigen may interact with other medications, and it is crucial to inform the healthcare provider of all the drugs the patient is currently taking. Immunosuppressive drugs, such as corticosteroids and chemotherapy agents, may reduce the effectiveness of Ismigen, as they dampen the immune response that Ismigen aims to enhance. Conversely, Ismigen might potentiate the effects of other immunostimulants, leading to an exaggerated immune response.
There is limited data on the interaction of Ismigen with vaccines, but it is generally recommended to avoid administering live vaccines concurrently with Ismigen to prevent potential interference with the vaccine's efficacy.
In summary, Ismigen has emerged as a valuable tool in the prevention of recurrent respiratory tract infections, particularly for individuals with compromised immune systems. By modulating the immune system, it enhances the body's natural defenses, reducing the frequency and severity of infections. While generally well-tolerated, it is essential to be aware of potential side effects and drug interactions to ensure safe and effective use. As research continues, the scope of Ismigen's applications may expand, offering new avenues for its use in immunotherapy.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


